Table 2 Cardiovascular magnetic resonance imaging findings (n = 41)

LVEF (%)

55.3 ± 15.3

34.4 ± 13.5

< 0.001

LVEDVI (ml/m²)

82.7 ± 30.3

103.4 ± 35.9

0.06

LVESVI (ml/m²)

40.7 ± 30.1

70.5 ± 36.4

0.008

LV mass indexed (g/m²)

78.6 ± 29.0

89.4 ± 33.5

0.31

Max LV thickness (mm)

12.2 ± 3.5

11.2 ± 2.8

0.35

RWMA (segments)

2.0 (IQR 0–3.0)

14.0 (IQR 3.8–16.0)

0.002

RVEF (%)

57.3 ± 10.9

42.9 ± 18.2

0.008

RVEDVI (ml/m²)

73.7 ± 22.1

83.9 ± 29.9

0.25

RVESVI (ml/m²)

33.0 ± 16.4

51.1 ± 29.6

0.03

Pericardial effusion (n, %)

16 (69.6)

11 (61.1)

0.75

T2-weighted

 STIR

  Positive (n, %)

21 (91.3)

11 (61.1)

0.03

  Total Segments (n)

3.0 (IQR 2.0–4.0)

1.0 (IQR 0–1.0)

0.003

  Signal intensity ratio

2.3 ± 0.5

2.6 ± 0.7

0.39

T1-weighted

 EGE

  Positive (n, %)

17 (73.9)

10 (55.6)

0.32

  Signal intensity ratio

8.1 (IQR 5.5–9.4)

4.1 (IQR 3.4–6.6)

0.06

 LGE

  Positive (n, %)

22 (95.7)

13 (72.2)

0.07

  Total segments (n)

4.5 (IQR 2.3–6.0)

2.0 (IQR 0–3.3)

0.02

 Pattern

  Inferolateral (n, %)

14 (60.8)

2 (11.1)

0.005

  Anteroseptal (n, %)

2 (8.7)

0

  Diffuse (n, %)

2 (8.7)

3 (16.7)

  Other (n, %)

4 (17.4)

8 (44.4)

Original LLC

 Positive (n, %)

21 (91.3)

10 (55.6)

0.01

Updated LLC

 Positive (n, %)

22 (95.7)

13 (72.2)

0.07